Assessing Smoking Behaviour and Tobacco Smoke Exposure: Definitions and Methods

Open access


In recent years, the increased availability of tobacco products other than conventional cigarettes, the use of puffing topography devices for smoking behaviour studies and the use of biomarkers to study smoke constituents exposure have generated the need for a more comprehensive set of definitions concerning smoking behaviour and exposure to smoke. The definitions offered in this paper are based on many years of practical experience and on consensus within a broad group of scientists working in these areas. It is intended that, with wider and more consistent usage, these definitions should reduce any misunderstandings and facilitate interpretation of future studies.

1. Lehmann, K.B.: Investigations on Tobacco Smoke [Untersuchungen über das Tabakrauchen]; Münch. Med. Wochenschr. 55 (1908) 723–725.

2. Pyriki, C.: On the Uptake of Nicotine in Cigarette Smoking [Über die Aufnahme des Nicotins beim Zigarettenrauchen]; Zeitschr. Unters. Lebensmittel 64 (1932) 163–171.

3. Baumberger, J.P.: The Amount of Smoke Produced from Tobacco and Its Absorption in Smoking as Determined by Electrical Precipitation; J. Pharmacol. Exp. Ther. 21 (1923) 47-57.

4. Baker, R.R. and M. Dixon: The Retention of Tobacco Smoke Constituents in the Human Respiratory Tract; Inhal. Toxicol. 18 (2006) 255-294.

5. Dickens, C, C. McGrath, N. Warren, P. Biggs, and J. McAughey: Puffing and Inhalation Behaviour in Cigarette Smoking: Implications for Particle Diameter and Dose; J. Phys. Conf. Ser. 151 (2009) 012019.

6. Smith, C.J., S.C. McKarns, R.A. Davis, S.D. Livings-ton, B.R. Bombick, J.T. Avalos, W.T. Morgan, and D.J. Doolittle: Human Urine Mutagenicity Study Comparing Cigarettes Which Burn or Primarily Heat Tobacco; Mutat. Res. 361 (1996) 1-9.

7. Schorp, M.K., A.R. Tricker, and R. Dempsey: Reduced Exposure Evaluation of an Electrically Heated Cigarette Smoking System. Part 1: Non-Clinical and Clinical Insights; Regul. Toxicol. Pharmacol 64. (2 Suppl.) (2012) S1-S10.

8. Tricker, A.R., AJ. Stewart, CM. Leroy, D. Lindner, M.K. Schorp, and R. Dempsey: Reduced Exposure Evaluation of an Electrically Heated Cigarette Smoking System. Part 3: Eight-Day Randomized Clinical Trial in the UK; Regul. Toxicol. Pharmacol. 64 (2 Suppl) (2012) S35-S44.

9. Vansickel, A.R. and T. Eissenberg: Electronic Cigarettes: Effective Nicotine Delivery after Acute Ad-ministration; Nicotine Tob. Res. 15 (2013) 267-270.

10. Brinkman, G.L. and E.O. Coates Jr: The Effect of Bronchitis, Smoking, and Occupation on Ventilation; Am. Rev. Respir. Dis. 87 (1963) 684-693.

11. Hamabe, A., H. Uto, Y. Imamura, K. Kusano, S. Mawatari, K. Kumagai, T. Kure, T. Tamai, A. Mori-uchi, T. Sakiyama, M. Oketani, A. Ido, and H. Tsu-bouchi: Impact of Cigarette Smoking on Onset of Nonalcoholic Fatty Liver Disease over a 10-Year Period; J. Gastroenterol. 46 (2011) 769-778.

12. Bernaards, CM., J.W. Twisk, J. Snel, W. van Meche-len, and H.C Kemper: Is Calculating Pack-Years Retrospectively a Valid Method to Estimate Life-Time Tobacco Smoking? A Comparison between Prospectively Calculated Pack-Years and Retrospectively Calculated Pack-Years; Addiction 96 (2001) 1653-1661.

13. Peto, J.: That the Effects of Smoking Should Be Measured in Pack-Years: Misconceptions 4; Br. J. Cancer 107 (2012) 406–407.

14. Burling, T.A., M.L. Stitzer, G.E. Bigelow, and A.M. Mead: Smoking Topography and Carbon Monoxide Levels in Smokers; Addict. Behav. 10 (1985) 319-323.

15. Hammond, D., G.T. Fong, K.M. Cummings, and A. Hyland: Smoking Topography, Brand Switching, and Nicotine Delivery: Results from an in vivo Study; Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1370-1375.

16. Matsumoto, M., Y. Inaba, I. Yamaguchi, O. Endo, D. Hammond, S. Uchiyama, and G. Suzuki: Smoking Topography and Biomarkers of Exposure among Japanese Smokers: Associations with Cigarette Emissions Obtained Using Machine Smoking Protocols; Environ. Health Prev. Med. 18 (2013) 95-103.

18. Ossip-Klein, D.J., J.E. Martin, B.D. Lomax, D.M. Prue, and C.J. Davis: Assessment of Smoking Topography Generalization across Laboratory, Clinical, and Naturalistic Settings; Addict. Behav. 8 (1983) 11–17.

19. Woodson, P.P. and R.R. Griffiths: Control of Cigarette Smoking Topography: Smoke Filtration and Draw Resistance; Behav. Pharmacol. 3 (1992) 99–111.

20. Ashton, H. and D.W. Watson: Puffing Frequency and Nicotine Intake in Cigarette Smokers; Br. Med. J. 3 (1970) 679–681.

21. Bättig, K., R. Buzzi, and R. Nil: Smoke Yield of Cigarettes and Puffing Behavior in Men and Women; Psychopharmacology 76 (1982) 139–148.

22. Bridges, R.B., J.G. Combs, J.W. Humble, J.A. Turbek, S.R. Rehm, and N.J. Haley: Puffing Topography as a Determinant of Smoke Exposure; Pharmacol. Biochem. Behav. 37 (1990) 29–39.

23. Nil, R., R. Buzzi, and K. Bättig: Effects of Different Cigarette Smoke Yields on Puffing and Inhalation: Is the Measurement of Inhalation Volumes Relevant for Smoke Absorption?; Pharmacol. Biochem. Behav. 24 (1986) 587–595.

24. Feng, S., S.E. Plunkett, K. Lam, S. Kapur, R. Muhammad, Y. Jin, M. Zimmermann, P. Mendes, R. Kinser, and H.J. Roethig: A New Method for Estimating the Retention of Selected Smoke Constituents in the Respiratory Tract of Smokers During Cigarette Smoking; Inhal. Toxicol. 19 (2007) 169–179.

25. Mariner, D. and J. Shepperd: Special Supplement Introduction: Estimating Cigarette Smoke Exposure by Filter Analysis; Regul. Toxicol. Pharmacol. 61 (3 Suppl) (2011) S1–S2.

26. Creighton, D.E., M.J. Nobel, and R.T. Whewell: Instruments to Measure, Record and Duplicate Human Smoking Patterns; in: Smoking Behaviour: Physiological and Psychological Influences, edited by R.E. Thornton, Churchill Livingstone, London, 1978, pp. 277–288.

27. Shepperd, C.J., F.K. St. Charles, M. Lien, and M. Dixon: Validation of Methods for Determining Consumer Smoked Cigarette Yields from Cigarette Filter Analysis; Beitr. Tabakforsch. Int. 22 (2006) 176–184.

28. St. Charles, F.K., M. Ashley, C.J. Shepperd, P. Clayton, and G. Errington: A Robust Method for Estimating Human Smoked Cigarette Yields from Filter Analysis Data; Beitr. Tabakforsch. Int. 23 (2009) 232–243.

29. Scherer, G.: Biomonitoring of Inhaled Complex Mixtures – Ambient Air, Diesel Exhaust and Cigarette Smoke; Exper. Toxicol. Pathol. 57 (2005) 75–110.

30. Shields, P.G.: Tobacco Smoking, Harm Reduction, and Biomarkers; J. Natl. Cancer Inst. 94 (2002) 1435–1444.

31. Stratton, K., P. Shetty, R. Wallace, and S. Bondurant (Editors): Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction; Institute of Medicine, The National Academies Press, Washington DC, 2001.

32. Institute of Medicine: Scientific Standards for Studies on Modified Risk Tobacco Products; The National Academies Press, Washington DC, 2012.

32. Hecht, S.S.: Human Urinary Carcinogen Metabolites: Biomarkers for Investigating Tobacco and Cancer; Carcinogenesis 23 (2002) 907–922.

33. Scherer, G.: Application of Biomarkers for the Evaluation of Potential Reduced-Exposure Products (PREPs); Rec. Adv. Tob. Sci. 32 (2006) 85–122.

34. International Organization for Standardization: ISO 10185:2004. Tobacco and Tobacco Products –Vocabulary; International Organization for Standardization, Geneva, 2004.

35. Baker, R.R., M. Dixon, D.C. Mariner, C.J. Shepperd, G. Scherer, M.W. Ogden, J.H. Robinson, N.M. Sinclair, N. Sherwood, Y. Akiyama, K. Sakamoto, W. Röper, A.R. Tricker, V. Marchand, B. Varignon, and G. Lionetti: Terms Used for Exposure to Smoke; Beitr. Tabakforsch. Int. 21 (2004) 250.

36. Burns, D.M., E. Dybing, N. Gray, S. Hecht, C. Anderson, T. Sanner, R. O'Connor, M. Djordjevic, C. Dresler, P. Hainaut, M. Jarvis, A. Opperhuizen, and K. Straif: Mandated Lowering of Toxicants in Cigarette Smoke: A Description of the World Health Organization TobReg Proposal; Tob. Control 17 (2008) 132–141.

37. Ashley, D.L., D.M. Burns, M. Djordjevic, E. Dybing, N. Gray, S.K. Hammond, J. Henningfield, M. Jarvis, K.S. Reddy, C. Robertson, and G. Zaatari (WHO Study Group on Tobacco Product Regulation): The Scientific Basis of Tobacco Product Regulation; WHO Technical Report Series 945, World Health Organization, Geneva, 2007.

38. Micheel, C. and J.R. Ball (Editors): Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine, The National Academies Press, Washington DC, 2010.

39. Mendes, P., S. Kapur, J. Wang, S. Feng, and H. Roe-thig: A Randomized, Controlled Exposure Study in Adult Smokers of Full Flavor Marlboro Cigarettes Switching to Marlboro Lights or Marlboro Ultra Lights Cigarettes; Regul. Toxicol. Pharmacol. 51 (2008) 295–305.

40. O'Connor, R.J., V.W. Rees, K.J. Norton, K.M. Cum-mings, G.N. Connolly, H.R. Alpert, A. Sjödin, L. Romanoff, Z. Li, K.M. June, and G.A. Giovino: Does Switching to Reduced Ignition Propensity Cigarettes Alter Smoking Behavior or Exposure to Tobacco Smoke Constituents?; Nicotine Tob. Res. 12 (2010) 1011–1018.

41. Marian, C., R.J. O'Connor, M.V. Djordjevic, V.W. Rees, D.K. Hatsukami, and P.G. Shields: Reconciling Human Smoking Behavior and Machine Smoking Patterns: Implications for Understanding Smoking Behavior and the Impact on Laboratory Studies; Cancer Epidemiol. Biomarkers Prev. 18 (2009) 3305–3320.

42. Rodenstein, D.O. and D.C. Stanescu: Pattern of Inhalation of Tobacco Smoke in Pipe, Cigarette, and Never Smokers; Am. Rev. Respir. Dis. 132 (1985) 628–632.

43. St. Charles, F.K., G.R. Krautter, and D.C. Mariner: Post-Puff Respiration Measures on Smokers of Different Tar Yield Cigarettes; Inhal. Toxicol. 21 (2009) 712–718.

44. National Research Council (U.S.), Committee on Improving Risk Analysis Approaches Used by the U.S. EPA: Science and Decisions: Advancing Risk Assessment; The National Academies Press, Washington DC, 2009, pp. 424.

45. International Programme on Chemical Safety (IPCS): IPCS Risk Assessment Terminology. Harmonization Project Document No. 1; World Health Organization, Geneva, 2004.

46. International Programme on Chemical Safety (IPCS): Characterization and Application of Physiologically Based Pharmacokinetic Models in Risk Assessment. Harmonization Project Document No. 9; World Health Organization, Geneva, 2010.

47. Armitage, A.K., M. Dixon, B.E. Frost, D.C. Mariner, and N.M. Sinclair: The Effect of Tobacco Blend Additives on the Retention of Nicotine and Solanesol in the Human Respiratory Tract and on Subsequent Plasma Nicotine Concentrations During Cigarette Smoking; Chem. Res. Toxicol. 17 (2004) 537–544.

48. Lowe, F.J., E.O. Gregg, and M. McEwan: Evaluation of Biomarkers of Exposure and Potential Harm in Smokers, Former Smokers and Never-Smokers; Clin Chem. Lab. Med. 47 (2009) 311–320.

49. Feng, S., H.J. Roethig, Q. Liang, R. Kinser, Y. Jin, G. Scherer, M. Urban, J. Engl, and K. Riedel: Evaluation of Urinary 1-Hydroxypyrene, S-Phenylmercapturic Acid, trans, trans-Muconic Acid, 3-Methyladenine, 3-Ethyladenine, 8-Hydroxy-2’-Deoxyguanosine and Thioethers as Biomarkers of Exposure to Cigarette Smoke; Biomarkers 11 (2006) 28–52.

50. Meger, M., I. Meger-Kossien, K. Riedel, and G. Scherer: Biomonitoring of Environmental Tobacco Smoke (ETS)-Related Exposure to 4-(Methylnitros-amino)-1-(3-Pyridyl)-1-Butanone (NNK); Biomarkers 5 (2000) 33–45.

51. Hatsukami, D.K., N.L. Benowitz, S.I. Rennard, C. Oncken, and S.S. Hecht: Biomarkers to Assess the Utility of Potential Reduced Exposure Tobacco Products; Nicotine Tob. Res. 8 (2006) 169–191 (Corrected and republished in Nicotine Tob. Res. 8 (2006) 600–22).

52. Hecht, S.S., J.-M. Yuan, and D. Hatsukami: Applying Tobacco Carcinogen and Toxicant Biomarkers in Product Regulation and Cancer Prevention; Chem. Res. Toxicol. 23 (2010) 1001–1008.

53. Heavner, D.L., W.T. Morgan, S.B. Sears, J.D. Richardson, G.D. Byrd, and M.W. Ogden: Effect of Creatinine and Specific Gravity Normalization Techniques on Xenobiotic Biomarkers in Smokers’ Spot and 24-h Urines; J. Pharm. Biomed. Anal. 40 (2006) 928–942.

54. Lindner, D., S. Smith, C.M. Leroy, and A.R. Tricker: Comparison of Exposure to Selected Cigarette Smoke Constituents in Adult Smokers and Nonsmokers in a European, Multicenter, Observational Study; Cancer Epidemiol. Biomarkers Prev. 20 (2011) 1524–1536.

55. Tricker, A.R.: Biomarkers Derived from Nicotine and Its Metabolites: A Review; Beitr Tabakforsch Int 22 (2006) 147–175.

56. Byrd, G.D., R.A. Davis, W.S. Caldwell, J.H. Robinson, and J.D. deBethizy: A Further Study of FTC Yield and Nicotine Absorption in Smokers; Psychopharmacology 139 (1998) 291–299.

57. Food and Drug Administration: Guidance for Industry: Bioanalytical Method Validation; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Rockville, MD, 2001.

58. Aggett, P.J., J.-M. Antoine, N.-G. Asp, F. Bellisle, L. Contor, J.H. Cummings, J. Howlett, D.J.G. Müller, C. Persin, L.T.J. Pijls, G. Rechkemmer, S. Tuijtelaars, and H. Verhagen: PASSCLAIM: Consensus on Criteria; Eur. J. Nutr. 44 (Suppl 1) (2005) i5–i30.

59. Angerer, J., L.L. Aylward, S.M. Hays, B. Heinzow, and M. Wilhelm: Human Biomonitoring Assessment Values: Approaches and Data Requirements; Int. J. Hyg. Environ. Health 214 (2011) 348–360.

60. International Organization for Standardization: ISO / IEC 17025:2005. General Requirements for the Competence of Testing and Calibration Laboratories; International Organization for Standardization, Geneva, 2005.

61. Lee, J.W., V. Devanarayan, Y.C. Barrett, R. Weiner, J. Allinson, S. Fountain, S. Keller, I. Weinryb, M. Green, L. Duan, J.A. Rogers, R. Millham, P.J. O'Brien, J. Sailstad, M. Khan, C. Ray, and J.A. Wagner: Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement; Pharm. Res. 23 (2006) 312–328.

62. Russell, M.A.H.: Low-Tar Medium-Nicotine Ciga-rettes: A New Approach to Safer Smoking; Br. Med. J. 1 (1976) 1430–1433.

63. Urban, H.-J., A.R. Tricker, D.E. Leyden, N. Forte, V. Zenzen, A. Feuersenger, M. Assink, G. Kallischnigg, and M.K. Schorp: Reduced Exposure Evaluation of an Electrically Heated Cigarette Smoking System. Part 8: Nicotine Bridging - Estimating Smoke Constituent Exposure by Their Relationships to Both Nicotine Levels in Mainstream Cigarette Smoke and in Smokers; Regul. Toxicol. Pharmacol. 64 (2 Suppl) (2012) S85–S97.

64. Andreoli, C., E.O. Gregg, R. Puntoni, V. Gobbi, A. Nunziata, and A. Bassi: Cross-Sectional Study of Biomarkers of Exposure and Biological Effect on Monozygotic Twins Discordant for Smoking; Clin. Chem. Lab. Med. 49 (2011) 137–145.

65. Calapai, G., A.P. Caputi, C. Mannucci, E.O. Gregg, A. Pieratti, G. Aurora Russo, N. Chaudhary, R. Puntoni, F. Lowe, M. McEwan, A. Bassi, S. Morandi, and A. Nunziata: A Cross-Sectional Investigation of Biomar-kers of Risk after a Decade of Smoking; Inhal. Toxicol. 21 (2009) 1138–1143.

66. Derby, K.S., K. Cuthrell, C. Caberto, S.G. Carmella, A.A. Franke, S.S. Hecht, S.E. Murphy, and L. Le Marchand: Nicotine Metabolism in Three Ethnic/ Racial Groups with Different Risks of Lung Cancer; Cancer Epidemiol. Biomarkers Prev. 17 (2008) 3526–3535.

67. Timofeeva, M.N., J.D. McKay, G.D. Smith, M. Johansson, G.B. Byrnes, A. Chabrier, C. Relton, P.M. Ueland, S.E. Vollset, O. Midttun, O. Nygard, N. Slimani, I. Romieu, F. Clavel-Chapelon, M.C. Boutron-Ruault, G. Fagherazzi, R. Kaaks, B. Teucher, H. Boeing, C. Weikert, H.B. Bueno-de-Mesquita, C. van Gils, P.H. Peeters, A. Agudo, A. Barricarte, J.M. Huerta, L. Rodriguez, M.J. Sanchez, N. Larranaga, K.T. Khaw, N. Wareham, N.E. Allen, R.C. Travis, V. Gallo, T. Norat, V. Krogh, G. Masala, S. Panico, C. Sacerdote, R. Tumino, A. Trichopoulou, P. Lagiou, D. Trichopoulos, T. Rasmuson, G. Hallmans, E. Riboli, P. Vineis, and P. Brennan: Genetic Polymorphisms in 15q25 and 19q13 Loci, Cotinine Levels, and Risk of Lung Cancer in EPIC; Cancer Epidemiol. Biomarkers Prev. 20 (2011) 2250–2261.

68. Tomashefski Jr, J.F., R.G. Crystal, H.P. Wiedemann, E. Mascha, and J.K. Stoller: The Bronchopulmonary Pathology of Alpha-1 Antitrypsin (AAT) Deficiency: Findings of the Death Review Committee of the National Registry for Individuals with Severe Deficiency of Alpha-1 Antitrypsin; Hum. Pathol. 35 (2004) 1452–1461.

69. Voors-Pette, C. and T.W. de Bruin: Excess Coronary Heart Disease in Familial Combined Hyperlipidemia, in Relation to Genetic Factors and Central Obesity; Atherosclerosis 157 (2001) 481–489.

70. Tabori, U. and D. Malkin: Risk Stratification in Cancer Predisposition Syndromes: Lessons Learned from Novel Molecular Developments in Li-Fraumeni Syndrome; Cancer Res 68 (2008) 2053–2057.

71. Doll, R., R. Peto, J. Boreham, and I. Sutherland: Mor-tality in Relation to Smoking: 50 Years’ Observations on Male British Doctors; Br. Med. J. 328 (2004) 1519.

72. St. Charles, F.K., G.R. Krautter, M. Dixon, and D.C. Mariner: A Comparison of Nicotine Dose Estimates in Smokers between Filter Analysis, Salivary Cotinine, and Urinary Excretion of Nicotine Metabolites; Psychopharmacology 189 (2006) 345–354.

73. International Organization for Standardization: ISO 3308:2012. Routine Analytical Cigarette-Smoking Machine – Definition and Standard Conditions; International Organization for Standardization, Geneva, 2012.

74. Scherer, G.: Carboxyhemoglobin and Thiocyanate as Biomarkers of Exposure to Carbon Monoxide and Hydrogen Cyanide in Tobacco Smoke; Exp. Toxicol. Pathol. 58 (2006) 101-124.

75. Ding, Y.S., B.C. Blount, L. Valentin-Blasini, H.S. Applewhite, Y. Xia, C.H. Watson, and D.L. Ashley: Simultaneous Determination of Six Mercapturic Acid Metabolites of Volatile Organic Compounds in Human Urine; Chem. Res. Toxicol. 22 (2009) 1018-1025.

76. Schlöbe, D., D. Hölzle, D. Hatz, L. von Meyer, A.R. Tricker, and E. Richter: 4-Hydroxy-1-(3-Pyridyl)-1-Butanone-Releasing DNA Adducts in Lung, Lower Esophagus and Cardia of Sudden Death Victims; Toxicology 245 (2008) 154-161.

77. Scherer, G., S. Frank, K. Riedel, I. Meger-Kossien, and T. Renner: Biomonitoring of Exposure to Polycyclic Aromatic Hydrocarbons of Nonoccupationally Exposed Persons; Cancer Epidemiol. Biomarkers Prev. 9 (2000) 373-380.

78. Talaska, G., M. Schamer, P. Skipper, S. Tannenbaum, N. Caporaso, L. Unruh, F.F. Kadlubar, H. Bartsch, C. Malaveille, and P. Vineis: Detection of Carcinogen-DNA Adducts in Exfoliated Urothelial Cells of Cigarette Smokers: Association with Smoking, Hemoglobin Adducts, and Urinary Mutagenicity; Cancer Epidemiol. Biomarkers Prev. 1 (1991) 61-66.

79. McEwen, W.: Breathe In, Breathe Out; Tob. J. Int. 5 (2010) 97.

Journal Information

CiteScore 2018: 0.69

SCImago Journal Rank (SJR) 2018: 0.295
Source Normalized Impact per Paper (SNIP) 2018: 0.491

Cited By


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 510 419 33
PDF Downloads 253 238 18